Related Experiment Video
Updated: May 24, 2026

Rapid Quantification of Mitogen-induced Blastogenesis in T Lymphocytes for Identifying Immunomodulatory Drugs
Published on: December 27, 2016
Corticosteroids and β₂-agonists upregulate mitogen-activated protein kinase phosphatase 1: in vitro mechanisms
M Manetsch1, E E Ramsay, E M King
1Respiratory Research Group, Faculty of Pharmacy, University of Sydney, Sydney, NSW, Australia.
Background And Purpose:
Airway remodelling is a consequence of long-term inflammation and MAPKs are key signalling molecules that drive pro-inflammatory pathways. The endogenous MAPK deactivator--MAPK phosphatase 1 (MKP-1)--is a critical negative regulator of the myriad pro-inflammatory pathways activated by MAPKs in the airway.
Experimental Approach:
Herein we investigated the molecular mechanisms responsible for the upregulation of MKP-1 in airway smooth muscle (ASM) by the corticosteroid dexamethasone and the β₂-agonist formoterol, added alone and in combination.
Key Results:
MKP-1 is a corticosteroid-inducible gene whose expression is enhanced by long-acting β₂-agonists in an additive manner. Formoterol induced MKP-1 expression via the β₂-adrenoceptor and we provide the first direct evidence (utilizing overexpression of PKIα, a highly selective PKA inhibitor) to show that PKA mediates β₂-agonist-induced MKP-1 upregulation. Dexamethasone activated MKP-1 transcription in ASM cells via a cis-acting corticosteroid-responsive region located between -1380 and -1266 bp of the MKP-1 promoter. While the 3'-untranslated region of MKP-1 contains adenylate + uridylate elements responsible for regulation at the post-transcriptional level, actinomycin D chase experiments revealed that there was no increase in MKP-1 mRNA stability in the presence of dexamethasone, formoterol, alone or in combination. Rather, there was an additive effect of the asthma therapeutics on MKP-1 transcription.
Conclusions And Implications:
Taken together, these studies allow us a greater understanding of the molecular basis of MKP-1 regulation by corticosteroids and β₂-agonists and this new knowledge may lead to elucidation of optimized corticosteroid-sparing therapies in the future.
Insights
Corticosteroids and formoterol upregulate MAPK phosphatase 1 (MKP-1) in airway smooth muscle by increasing its transcription. This provides insights into optimizing therapies for airway inflammation and remodeling.
Area of Science:
- Pulmonary Medicine
- Molecular Biology
- Pharmacology
Background:
- Airway remodeling results from chronic inflammation, with mitogen-activated protein kinases (MAPKs) driving pro-inflammatory pathways.
- MAPK phosphatase 1 (MKP-1) is a crucial endogenous inhibitor of MAPK-activated inflammatory signaling in the airway.
Purpose of the Study:
- To investigate the molecular mechanisms by which dexamethasone and formoterol upregulate MKP-1 expression in airway smooth muscle (ASM).
- To elucidate the roles of protein kinase A (PKA) and transcriptional regulation in mediating these effects.
Main Methods:
- Investigated MKP-1 expression in ASM cells treated with dexamethasone and formoterol, alone and in combination.
- Utilized PKIα (a PKA inhibitor) to assess PKA's role in β₂-agonist-induced MKP-1 upregulation.
- Analyzed MKP-1 promoter activity and mRNA stability using reporter assays and actinomycin D chase experiments.
Main Results:
- MKP-1 is a corticosteroid-inducible gene, with expression enhanced additively by long-acting β₂-agonists like formoterol.
- Formoterol upregulates MKP-1 via the β₂-adrenoceptor, mediated by PKA signaling.
- Dexamethasone increases MKP-1 transcription through a specific corticosteroid-responsive element in the promoter; mRNA stability is not affected.
Conclusions:
- Dexamethasone and formoterol primarily enhance MKP-1 expression through additive transcriptional upregulation in ASM.
- Understanding these regulatory mechanisms is key to developing improved corticosteroid-sparing therapies for airway diseases.
- This research deepens the understanding of MKP-1 regulation by common asthma medications.
More Related Videos
08:49Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
Published on: January 22, 2019
09:32Light-mediated Reversible Modulation of the Mitogen-activated Protein Kinase Pathway during Cell Differentiation and Xenopus Embryonic Development
Published on: June 15, 2017
Related Concept Videos
Mitogens and the Cell Cycle
MAPK Signaling Cascades
cAMP-dependent Protein Kinase Pathways
GPCRs Regulate Adenylyl Cylase Activity
Two...
Amplifying Signals via Enzymatic Cascade
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...